News

Yahoo Finance24d
Imperative Care Expands Symphony Precision Thrombectomy Portfolio with Purpose-Built Design for the Treatment of Venous Thrombosis
CAMPBELL, Calif., March 24, 2025--(BUSINESS WIRE)--Imperative Care, Inc. today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the 82cm version of its Symphony™ 16F Cathete ...
TMCnet2d
Instylla Announces the Appointment of Daniel Davis to Board of Directors
BEDFORD, Mass., April 15, 2025 /PRNewswire/ -- Instylla, Inc., a privately held clinical-stage company developing solutions for peripheral vascular embolization, has announced the appointment of ...
Enid News & Eagle24d
Imperative Care Expands Symphony Precision Thrombectomy Portfolio with Purpose-Built Design for the Treatment of Venous Thrombosis
Imperative Care, Inc. today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the 82cm version of its Symphony™ 16F Catheter, the company’s latest innovation designed to ...
Morningstar24d
Imperative Care Expands Symphony Precision Thrombectomy Portfolio with Purpose-Built Design for the Treatment of Venous Thrombosis
Symphony Thrombectomy System is designed to efficiently maximize clot removal with a focus on minimizing blood loss Imperative Care, Inc. today announced U.S. Food and Drug Administration (FDA ...